Website: Astaxanthin and its Effects in Inflammatory Responses and Inflammation-Associated Diseases: Recent Advances and Future Directions - PubMed (nih.gov)

• resources

                            Title & authors                            Abstract                                Conflict of interest statement                            Figures                            Similar articles                            References                        Publication types                        MeSH terms                        Substances                                    Related information                            LinkOut - more resources                

Review

 

. 2020 Nov 16;25(22):5342.

 doi: 10.3390/molecules25225342.

Astaxanthin and its Effects in Inflammatory Responses and Inflammation-Associated Diseases: Recent Advances and Future Directions

Ming Xian Chang 1 2 3, Fan Xiong 1

Affiliations 

• PMID: 33207669
 
• PMCID: PMC7696511
 
• DOI: 10.3390/molecules25225342

Free PMC article

Abstract

Astaxanthin is a natural lipid-soluble and red-orange carotenoid. Due to its strong antioxidant property, anti-inflammatory, anti-apoptotic, and immune modulation, astaxanthin has gained growing interest as a multi-target pharmacological agent against various diseases. In the current review, the anti-inflammation mechanisms of astaxanthin involved in targeting for inflammatory biomarkers and multiple signaling pathways, including PI3K/AKT, Nrf2, NF-κB, ERK1/2, JNK, p38 MAPK, and JAK-2/STAT-3, have been described. Furthermore, the applications of anti-inflammatory effects of astaxanthin in neurological diseases, diabetes, gastrointestinal diseases, hepatic and renal diseases, eye and skin disorders, are highlighted. In addition to the protective effects of astaxanthin in various chronic and acute diseases, we also summarize recent advances for the inconsistent roles of astaxanthin in infectious diseases, and give our view that the exact function of astaxanthin in response to different pathogen infection and the potential protective effects of astaxanthin in viral infectious diseases should be important research directions in the future.

Keywords: anti-inflammatory; astaxanthin; inflammation-associated diseases; oxidative stress.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1 

Chemical structures of selected carotenoids.

 

Figure 2 

The anti-inflammation mechanisms of astaxanthin.…

Similar articles

• Astaxanthin protects lipopolysaccharide-induced inflammatory response in Channa argus through inhibiting NF-κB and MAPKs signaling pathways.

  Li MY, Sun L, Niu XT, Chen XM, Tian JX, Kong YD, Wang GQ.Fish Shellfish Immunol. 2019 Mar;86:280-286. doi: 10.1016/j.fsi.2018.11.011. Epub 2018 Nov 15.PMID: 30448447
• Astaxanthin Suppresses PM2.5-Induced Neuroinflammation by Regulating Akt Phosphorylation in BV-2 Microglial Cells.

  Kim RE, Shin CY, Han SH, Kwon KJ.Int J Mol Sci. 2020 Sep 30;21(19):7227. doi: 10.3390/ijms21197227.PMID: 33008094 Free PMC article.
• On the Neuroprotective Role of Astaxanthin: New Perspectives?

  Galasso C, Orefice I, Pellone P, Cirino P, Miele R, Ianora A, Brunet C, Sansone C.Mar Drugs. 2018 Jul 24;16(8):247. doi: 10.3390/md16080247.PMID: 30042358 Free PMC article. Review.
• Astaxanthin, oxidative stress, inflammation and cardiovascular disease.

  Fassett RG, Coombes JS.Future Cardiol. 2009 Jul;5(4):333-42. doi: 10.2217/fca.09.19.PMID: 19656058 Review.
• Inhibitory effects of astaxanthin on azoxymethane-induced colonic preneoplastic lesions in C57/BL/KsJ-db/db mice.

  Kochi T, Shimizu M, Sumi T, Kubota M, Shirakami Y, Tanaka T, Moriwaki H.BMC Gastroenterol. 2014 Dec 17;14:212. doi: 10.1186/s12876-014-0212-z.PMID: 25515685 Free PMC article.

See all similar articles

References

1. 1. Zarneshan S.N., Fakhri S., Farzaei M.H., Khan H., Saso L. Astaxanthin targets PI3K/Akt signaling pathway toward potential therapeutic applications. Food Chem. Toxicol. 2020;145:111714. doi: 10.1016/j.fct.2020.111714. - DOI - PubMed
2. 1. Zheng Y.F., Bae S.H., Kwon M.J., Park J.B., Choi H.D., Shin W.G., Bae S.K. Inhibitory effects of astaxanthin, β-cryptoxanthin, canthaxanthin, lutein, and zeaxanthin on cytochrome P450 enzyme activities. Food Chem. Toxicol. 2013;59:78–85. doi: 10.1016/j.fct.2013.04.053. - DOI - PubMed
3. 1. Bjerkeng B., Peisker M., Schwartzenberg K.V., Ytrestøyl T., Åsgård T. Digestibility and muscle retention of astaxanthin in Atlantic salmon, Salmo salar, fed diets with the red yeast Phaffia rhodozyma in comparison with synthetic formulated astaxanthin. Aquaculture. 2007;269:476–489. doi: 10.1016/j.aquaculture.2007.04.070. - DOI
4. 1. Wang C., Armstrong D.W., Chang C.D. Rapid baseline separation of enantiomers and a mesoform of all-trans-astaxanthin, 13-cis-astaxanthin, adonirubin, and adonixanthin in standards and commercial supplements. J. Chromatogr. A. 2008;1194:172–177. doi: 10.1016/j.chroma.2008.04.063. - DOI - PubMed
5. 1. Stewart J.S., Lignell A., Pettersson A., Elfving E., Soni M.G. Safety assessment of astaxanthin-rich microalgae biomass: Acute and subchronic toxicity studies in rats. Food Chem. Toxicol. 2008;46:3030–3036. doi: 10.1016/j.fct.2008.05.038. - DOI - PubMed

Publication types